LOW BIOAVAILABILITY OF CYCLOSPORINE MICROEMULSION AND TACROLIMUS IN A SMALL BOWEL TRANSPLANT RECIPIENT
- 1 January 1999
- journal article
- case report
- Published by Wolters Kluwer Health in Transplantation
- Vol. 67 (2) , 333-335
- https://doi.org/10.1097/00007890-199901270-00026
Abstract
With intestine transplants the allograft is dependent on itself for maintenance of adequate immunosuppression. We evaluated an intestinal transplant recipient who required very large doses of either tacrolimus or cyclosporine emulsion to achieve acceptable blood concentrations. Pharmacokinetic studies revealed bioavailabilities of 2% and 6% respectively, while D-xylose and B12 absorption were found to be within normal limits and fecal fat was only slightly increased, suggesting that there was a selective absorptive defect for these drugs. Biopsies of the allograft ileum revealed a high P-glycoprotein activity compared to the jejunum or to intestinal biopsies from other normal subjects. This may be a contributing factor to poor immunosuppressive drug absorption in this patient and others.Keywords
This publication has 6 references indexed in Scilit:
- Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine*Clinical Pharmacology & Therapeutics, 1997
- Current results of intestinal transplantationThe Lancet, 1996
- The effects of ketoconazole on the intestinal metabolism and bioavailability of cyclosporine*Clinical Pharmacology & Therapeutics, 1995
- Pharmacokinetics of FK506 After Intravenous and Oral Administration in Patients Awaiting Renal TransplantationThe Journal of Clinical Pharmacology, 1994
- Improved Dose Linearity of Cyclosporine Pharmacokinetics from a Microemulsion FormulationPharmaceutical Research, 1994
- Altered patterns of drug metabolism in patients with acquired immunodeficiency syndromeClinical Pharmacology & Therapeutics, 1993